BIOVECTRA -  A part of Agilent

BIOVECTRA - A part of Agilent

Categories

MANUFACTURING/PROCESSINGBIOSCIENCELABRATORY - RESEARCH & TESTING

About Us

BIOVECTRA is a North American CDMO specializing in clinical-to-commercial scale production capabilities for:

- Biologics
- Synthetic small molecules
- pDNA and mRNA
- Highly potent APIs
- Bioreagents

Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and perfect innovative technologies and drug substance development approaches to deliver world-class solutions for pharmaceutical manufacturing.

We thrive on the vexing challenges few CDMOs would have the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization.

We care. We care about your projects. We care about quality. We care about innovation. We care about high quality pharmaceutical manufacturing.

Video Media

Rep/Contact Info

Valana Deighan
General Counsel
Heather Delage
Chief Commercial Officer
Ted Dolan
Chief Operating Officer
Scott Doncaster
Vice President, Strategic Projects
David Long
Chief Financial Officer
Peter Phillips
Vice President, Quality
Marc Sauer
Chief Scientific Officer
Mr. Oliver Technow
Chief Executive Officer
Ms. Bobbi Jo Walker
Director, Corporate Communications
Lois Washington
Manager, Administration
Mark Wellman
Vice President & General Manager, Complex Chemistry
Lester Wood
Vice President, People & Corporate Culture

Subscribe to our E-News

You have Successfully Subscribed!